Arix Bioscience

Investor type

VC

Founded

2016

AUM

-

Location

London, England, United Kingdom

Investment Ticket

$0-1 m

Investment Stage

Seed Series B

Region of investment

Europe
Investor profile last updated: 22 August, 2026

Profile

Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

Industry

Healthcare Services Life Sciences HealthTech

Contacts

Name
Title
Email
avatar
Gita Dittmar Venture Partner
Venture Partner
g•••@•••
avatar
Tim Xu MD MPP Principal
Principal
t•••@•••
Upgrade to see contacts
avatar
FNDjogEK3npye549 FNDjogEK3npye549
FNDjogEK3npye549
avatar
FNDjogEK3npye549 FNDjogEK3npye549
FNDjogEK3npye549
avatar
FNDjogEK3npye549 FNDjogEK3npye549
FNDjogEK3npye549
Investment-team contacts for Arix Bioscience — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Arix Bioscience

Arix Bioscience is a venture capital firm. It backs companies at Seed and Series B, writing tickets of $0-1 m.
Arix Bioscience is located in London, England, United Kingdom.
Arix Bioscience was founded in 2016.
Arix Bioscience invests in companies and startups in Healthcare Services, Life Sciences, HealthTech.
Arix Bioscience invests in companies and startups in Europe.
Arix Bioscience invests in companies and startups at Seed, Series B.
Arix Bioscience usually invests $0-1 m on average.
Arix Bioscience can be reached through its website arixbioscience.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Arix Bioscience — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Arix Bioscience directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 22 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.